Abstract:Abstract Background Gastric cancer (GC) is a common and aggressive type of cancer worldwide. Despite recent advancements in its treatment, the prognosis for patients with GC remains poor. Understanding the mechanisms of cell death in GC, particularly those related to mitochondrial function, is crucial for its development and progression. However, more research is needed to investigate the significance of the interaction between mitochondrial function and GC cell death. Methods We employed a robust computational framework to investigate the role of mitochondria-associated proteins in the progression of GC in a cohort of 1,199 GC patients. Ten machine learning algorithms were utilized and combined into 101 unique combinations. Ultimately, we developed a Mitochondrial-related-Score (MitoScore) using the machine learning model that exhibited the best performance. We observed the upregulation of LEMT2 and further explored its function in tumor progression. Mitochondrial functions were assessed by measuring mitochondrial ATP, mitochondrial membrane potential, and levels of lactate, pyruvate, and glucose. Results MitoScore showed significant correlations with GC immune and metabolic functions. The higher MitoScore subgroup exhibited enriched metabolic pathways and higher immune activity. Overexpression of LETM2 (leucine zipper and EF-hand containing transmembrane protein 2) significantly enhanced tumor proliferation and metastasis. LETM2 plays a role in promoting GC cell proliferation by activating the mTOR pathway, maintaining mitochondrial homeostasis, and promoting glycolysis. Conclusion The powerful machine learning framework highlights the significant potential of MitoScore in providing valuable insights and accurate assessments for individuals with GC. This study also enhances our understanding of LETM2 as an oncogene signature in GC. LETM2 may promote tumor progression by maintaining mitochondrial health and activating glycolysis, offering potential targets for diagnosis, treatment, and prognosis of GC.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the prognostic assessment of gastric cancer (GC) patients and the prediction of treatment effects. Specifically, the researchers are concerned with the relationship between mitochondrial function and gastric cancer cell death, and how to use this relationship to develop more effective prognostic models. By integrating multi - omics analysis and machine - learning techniques, they aim to establish a mitochondrial - function - based prognostic model (MitoScore) to provide an accurate assessment of the prognosis of gastric cancer patients and provide guidance for personalized treatment. ### Main research objectives: 1. **Understand the relationship between mitochondrial function and gastric cancer progression**: Explore the role of mitochondrial - related proteins in gastric cancer progression, especially how these proteins affect cell metabolism and immune function. 2. **Develop a prognostic model**: Use machine - learning algorithms to construct a model (MitoScore) that can accurately predict the prognosis of gastric cancer patients. 3. **Verify the effectiveness of the model**: Verify the predictive performance of the MitoScore model through internal and external data sets. 4. **Explore the function of key genes**: Focus on the expression of LEUCINE ZIPPER AND EF - HAND CONTAINING TRANSMEMBRANE PROTEIN 2 (LETM2) in gastric cancer and its impact on tumor progression. ### Research methods: - **Data collection**: Obtain RNA - sequencing data and clinical information from the TCGA and GEO databases. - **Differential expression gene analysis**: Use the limma package for differential expression gene (DEG) analysis. - **Machine - learning model construction**: Combine multiple machine - learning algorithms (such as SVM, Lasso, GBM, etc.), screen out 12 key genes through the NMF algorithm, and finally construct the MitoScore model. - **Survival analysis**: Use Kaplan - Meier survival analysis to evaluate the prognostic value of MitoScore. - **Single - cell sequencing analysis**: Analyze single - cell sequencing data in the GEO database to further verify the biological significance of the MitoScore model. - **Functional enrichment analysis**: Through KEGG, GSVA and GSEA analysis, explore the biological functions and pathway enrichment of the high - MitoScore and low - MitoScore subgroups. ### Main findings: - **Prognostic value of the MitoScore model**: MitoScore is significantly associated with the immune and metabolic functions of gastric cancer patients. The high - MitoScore subgroup shows higher metabolic pathway enrichment and immune activity. - **Role of LETM2**: Overexpression of LETM2 significantly enhances tumor proliferation and metastasis, maintains mitochondrial homeostasis and promotes glycolysis by activating the mTOR pathway. - **Predictive performance of the model**: The MitoScore model performs well in multiple external data sets and can effectively distinguish high - risk and low - risk patients. ### Conclusion: This study successfully developed a mitochondrial - function - based prognostic model, MitoScore, by integrating multi - omics data and machine - learning techniques, providing a new tool for the prognostic assessment of gastric cancer patients. At the same time, the study revealed that LETM2, as an oncogene marker in gastric cancer, may promote tumor progression by maintaining mitochondrial health and activating glycolysis, providing potential targets for the diagnosis, treatment and prognosis of gastric cancer.

Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric Cancer

Machine learning and single-cell sequencing reveal the potential regulatory factors of mitochondrial autophagy in the progression of gastric cancer

Construction of molecular subtype and prognostic model for gastric cancer based on nucleus-encoded mitochondrial genes

Unveiling the Power of Mitochondrial Fission and Fusion: A Five-Gene Signature for Personalized Prognosis in Gastric Cancer

Development and validation of a hypoxia- and mitochondrial dysfunction- related prognostic model based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer

Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes

The exploration of mitochondrial-related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer

A Novel Mitochondrial-Related Gene Signature for the Prediction of Prognosis and Therapeutic Efficacy in Lower-Grade Glioma

Integrative multi-omics analysis unveils the connection between transcriptomic characteristics associated with mitochondria and the tumor immune microenvironment in lower-grade gliomas

Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma

Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models

Mitochondria-Related Transcriptome Characterization Associated with the Immune Microenvironment, Therapeutic Response and Survival Prediction in Pancreatic Cancer

Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer

IDDF2024-ABS-0182 Exploring the Role of Mitochondrial Dynamics-Related Genes in the Molecular Classification and Prognostic Value of Liver Hepatocellular Carcinoma

Multi-omic profiling reveals potential biomarkers of hepatocellular carcinoma prognosis and therapy response among mitochondria-associated cell death genes in the context of 3P medicine

A novel mitochondria‐related core gene signature to predict the prognosis and evaluate tumour microenvironment in CESC single‐cell validation

Integrating Bioinformatics and Experimental Validation to Identify Mitochondrial Permeability Transition-Driven Necrosis-Related lncRNAs that can Serve as Prognostic Biomarkers and Therapeutic Targets in Endometrial Carcinoma

Identifying mitophagy-related genes as prognostic biomarkers and therapeutic targets of gastric carcinoma by integrated analysis of single-cell and bulk-RNA sequencing data

Construction and validation of prognostic signatures related to mitochondria and macrophage polarization in gastric cancer

Multi-omics Combined with Machine Learning Facilitating the Diagnosis of Gastric Cancer

Constructing and Evaluating a Mitophagy-Related Gene Prognostic Model: Implications for Immune Landscape and Tumor Biology in Lung Adenocarcinoma